center for tobacco Criticism as Brian King Named Director of FDA Products center for tobacco products -

it was not designed to provide general population estimates of perceived dependence on different TNPs, nor can it indicate the physiological addiction or abuse liability of TNPs

However, uncertainty regarding the number of high spending ACOs that would participate in response to a HEBA, combined with uncertainty regarding high spending ACOs' savings potential, results in a wide range of potential impacts in total over that 10 year period, from $2.3 billion in net savings at the 10th percentile (that is, only 10 percent of stochastic trials reduced Federal spending by a greater magnitude than $2.3 billion) to $1.2 billion in net spending at the 90th percentile

Dimensions: 2 x Panel - 63 x 36

Transparency defines trust